Mayo Clinic Laboratories Invests in Pathology Asia Holdings and LifeStrands Genomics to Advance Diagnostics and Precision Medicine
- Written by: PR Newswire Asia - News Pronto RSS
 |
SINGAPORE, Sept. 23, 2026 /PRNewswire/ -- Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precision medicine across Southeast Asia, Australia and New Zealand.
Mayo Clinic Laboratories and PAH are deepening a long-term...